Synthetic pulmonary surfactant preparations: new developments and future trends

Area of Science:

• Pulmonary medicine
• Biomaterials science
• Respiratory physiology

Background:

• Pulmonary surfactant is a critical lipid-protein complex for alveolar function, reducing respiratory work and preventing lung collapse.
• Deficiency or dysfunction of pulmonary surfactant is implicated in infant respiratory distress syndrome (IRDS) and acute respiratory distress syndrome (ARDS).
• Current exogenous surfactant therapies rely on animal lung extracts, which have limitations including batch variability, high costs, limited sources, and potential risks of infection and immunological reactions.

Purpose of the Study:

• To review current efforts and progress in developing novel synthetic pulmonary surfactants.
• To discuss modifications of existing exogenous surfactants to enhance their activity.
• To highlight the development of entirely new synthetic surfactant preparations.

Main Methods:

• Review of literature on pulmonary surfactant research and development.
• Analysis of strategies for modifying existing animal-derived surfactants.
• Evaluation of progress in creating completely synthetic surfactant alternatives.

Main Results:

• Natural surfactants, while effective, present significant drawbacks including variability, cost, limited supply, and safety concerns.
• Research is actively exploring modifications to existing surfactants and the creation of novel synthetic materials.
• Advancements are being made towards producing highly controlled and consistent synthetic surfactant preparations.

Conclusions:

• The limitations of natural pulmonary surfactants necessitate the development of controlled synthetic alternatives.
• Ongoing research focuses on enhancing existing treatments and creating fully synthetic options.
• Synthetic pulmonary surfactants offer a promising future for treating respiratory distress syndromes with improved safety and consistency.